Cote d'Ivoire vs Guinea-Bissau: Share of one-year-olds vaccinated against Streptococcus pneumoniae
Cote d'Ivoire
75.0%
in 2024
Guinea-Bissau
74.0%
in 2024
Cote d'Ivoire rank
115th
Guinea-Bissau rank
118th
Share of one-year-olds vaccinated against Streptococcus pneumoniae over time
- Cote d'Ivoire
- Guinea-Bissau
How they compare
Cote d'Ivoire currently reports 75.0% against 74.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Cote d'Ivoire ahead.
Cote d'Ivoire ranks 115th and Guinea-Bissau ranks 118th of 146 countries.
Across the 2 decades both report, Cote d'Ivoire averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Cote d'Ivoire | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.4% | 66.4% | 12.0% | Cote d'Ivoire |
| 2020s | 71.4% | 72.6% | 1.2% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against streptococcus pneumoniae, Cote d'Ivoire or Guinea-Bissau?
- Cote d'Ivoire, at 75.0% against 74.0% in Guinea-Bissau as of 2024.
- What is the difference in share of one-year-olds vaccinated against streptococcus pneumoniae between Cote d'Ivoire and Guinea-Bissau?
- 1.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Guinea-Bissau?
- 10 years are reported by both, from 2015 to 2024.
- How do Cote d'Ivoire and Guinea-Bissau rank globally for share of one-year-olds vaccinated against streptococcus pneumoniae?
- Cote d'Ivoire ranks 115th and Guinea-Bissau ranks 118th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Streptococcus pneumoniae. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.